Three new Tisch University Professors named

Three new Tisch University Professors – Nicholas Abbott, Catherine Kling and Daniel Lee – were named earlier this month by the Cornell University Board of Trustees, bringing to six the total number of current faculty carrying the honor and title.

Ezra

Two-step training helps robots interpret human language

To help robots understand human language when navigating, researchers divided their task into two separate stages: first, interpreting the language in a command and mapping out a path; and then executing the trip.

ILR interns explore ways autistic students can move from college to work

Two ILR School students worked this summer to smooth the transition for autistic students moving from college into the workforce.

2019 endowed benefits open enrollment has begun

Benefits open enrollment for endowed faculty and staff began Thursday, Nov. 1, and will continue until 4 p.m. EST, Monday, Nov. 19.

Staff News

ILR event to feature alums in sports industry leadership

The commissioner of the NHL and other ILR School and Cornell alumni will headline the Cornell ILR Sports Leadership Summit Nov. 15 in New York City.

Alzheimer’s symposium explores new neuroscience frontiers

World experts in neurodegenerative diseases gathered at Weill Cornell Medicine Sept. 25 to present the latest discoveries in the study and treatment of Alzheimer's disease.

Global Grand Challenges event to spark faculty dialogue

Cross-campus gathering will focus on the biggest challenges facing the world, and help determine a theme on which the university will focus in the 2019-2020 academic year.

President Pollack responds to recent acts of hatred in US

President Martha E. Pollack sent a message to the Cornell community in response to recent acts of hatred in the U.S. She urged all members of the campus community to support one another.

New Weill Cornell Medicine investigators hunt for HIV cure

As therapies for HIV have advanced to help many patients control the infection as a chronic disease, investigators and patients have set their sights on a new goal: finding a cure. Drs. Douglas Nixon and Brad Jones have recently joined Weill Cornell Medicine in the hopes of accelerating that hunt.